A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?

European Archives of Psychiatry and Clinical Neuroscience, May 2019

Andrea Schmitt, Mikael Simons, Ludovico Cantuti-Castelvetri, Peter Falkai

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:


A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?

European Archives of Psychiatry and Clinical Neuroscience pp 1–2 | Cite as A new role for oligodendrocytes and myelination in schizophrenia and affective disorders? AuthorsAuthors and affiliations Andrea SchmittMikael SimonsLudovico Cantuti-CastelvetriPeter Falkai Editorial First Online: 10 May 2019 An important part of human brain development is myelination of axons and development of white matter, which occurs at a high rate in the first years of childhood and continues until young adulthood. Myelination is dependent on proper oligodendrocyte function at all stages of development. Consequently, oligodendrocyte dysfunction leads to disturbances in myelination and connectivity and—on the functional level—also to cognitive deficits. In a diffusion tensor imaging (DTI) study, oligodendrocyte-related gene variants, such as myelin-associated glycoprotein (MAG), were related to white matter tract integrity and cognitive performance in SZ patients. Interestingly, a single nucleotide polymorphism of the oligodendrocyte transcription factor Olig2, which is necessary for maturation of oligodendrocyte precursor cells (OPCs), has also been associated with reduced white matter fractional anisotropy in schizophrenia [1]. Several meta-analyses of voxel-based DTI studies revealed reduced fractional anisotropy as a measure of deficits in fiber density and myelination in left frontal and temporal lobe white matter in patients with schizophrenia and affective disorders. Using high-immersion oil microscopy, Williams et al. detected decreased myelin cross-sectional area per axon in the splenium of patients with major depression [2]. In the entorhinal cortex of schizophrenia patients, we detected a decreased intensity of myelin basic protein (MBP) staining and found that decreased myelination correlated with disorganization of pre-alpha cells [3], demonstrating that disturbed neurodevelopment in these disorders might be the basis of disturbed myelin-based connectivity. In the gray matter of the prefrontal cortex, Kolomeets and Uranova report a reduction of the density of oligodendrocytes in schizophrenia [4]. Moreover, previous electron microscopy studies from that group in cases with very low postmortem intervals (time from death to autopsy) provided evidence for damaged myelin sheaths, myelin degeneration, and apoptosis/necrosis of oligodendrocytes in gray and white matter of the prefrontal cortex of patients with schizophrenia and affective disorders. A recent review of neuropathological findings in affective disorders, namely bipolar disorder, summarizes a loss of oligodendrocyte density in the gray or white matter of the prefrontal cortex and fronto-limbic network [5]. In design-based stereological postmortem studies, our group showed a decreased oligodendrocyte number in the left cornu ammonis 4 (CA4) region of the anterior and posterior hippocampus in schizophrenia but no alterations in neuron or astrocyte number [6]. Interestingly, we found that the reduction of oligodendrocytes was confined to the CA4 region, a region that is now regarded as a polymorph layer of the dentate gyrus. The CA4 region connects the dentate gyrus, where in animals neurogenesis can be observed, with the CA3 region. Moreover, we found that patients with marked cognitive deficits had a decreased number of oligodendrocytes in CA4, CA2/3, and the subiculum of the anterior hippocampus [7]. This led to the hypothesis that the decreased number of oligodendrocytes is a result of a failure of maturation and also indicates disturbed regeneration in the CA4/dentate region underlying impaired long-term outcome. However, to date it is unknown whether a failure in differentiation of OPCs, which are still capable of myelination or a loss of mature oligodendrocytes, contributes to the loss of oligodendrocyte number. In schizophrenia and affective disorders, the relationship of oligodendrocytes with interneuron pathology is unknown. A large fraction of myelinating oligodendrocytes ensheathes fast-spiking parvalbuminergic interneurons [8]. Intriguingly, myelin that is formed around these axons shows an unusual pattern, with a patchy distribution and myelinated segments preferentially localizing to the axon arbor near the cell body [8, 9]. Since this pattern of myelination is unlikely to support saltatory nerve conduction, it raises the question of its function. The fast-spiking and very high tonic activity of parvalbuminergic-positive inhibitory basket cells may require the function of myelin in supporting their high-energy demands. Energetic support of the axonal intermediate metabolism is provided by the delivery by glycolytic oligodendrocytes of lactate to axons. In fact, myelin deprives axons from rapid access to extracellular metabolites, which necessitates that lactate is delivered by oligodendrocytes to myelin and from there into the axon. This concept of metabolic coupling of myelin and axons is an important new development in neuroscience [10], but it remains to be established if all types of neurons need this metabolic support. In patients with schizophrenia and affective disorders, pathology of interneurons, including decreased expression of glutamic acid decarboxylase 67 (GAD67) and parvalbumin, has been detected in postmortem hippocampus and prefrontal cortex. In schizophrenia and affective disorders, the concept of metabolic coupling may link oligodendrocyte to interneuron pathology. Further studies in animal models and human brains are needed to shed light on this pathophysiological concept. If findings in preclinical studies are positive, similar to first clinical studies in multiple sclerosis new add-on treatment strategies targeting oligodendrocyte differentiation can be developed, which address treatment-resistant symptoms in schizophrenia and affective disorders. References 1. Voineskos AN, Felsky D, Kovacevic N, Tiwari AK, Zai C, Chakravarty MM, Lobaugh NJ, Shenton ME, Rajji TK, Miranda D, Pollock BG, Mulsant BH, McIntosh AR, Kennedy JL (2013) Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. Cereb Cortex 23(9):2044–2057CrossRefGoogle Scholar 2. Williams MR, Sharma P, Macdonald C, Pearce RKB, Hirsch SR, Maier M (2019) Axonal myelin decrease in the splenium in major depressive disorder. Eur Arch Psychiatry Clin Neurosci.  https://doi.org/10.1007/s00406-018-0904-4 Google Scholar 3. Parlapani E, Schmitt A, Erdmann A, Bernstein HG, Breunig B, Gruber O, Petroianu G, von Wilmsdorff M, Schneider-Axmann T, Honer W, Falkai P (2009) Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res 1301:126–134CrossRefGoogle Scholar 4. Kolomeets NS, Uranova NA (2019) Reduced oligodendrocyte density in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci.  https://doi.org/10.1007/s00406-018-0888-0 Google Scholar 5. Bellani M, Boschello F, Delvecchio G, Dusi N, Altamura CA, Ruggeri M, Brambilla P (2016) Front Psychiatry 7:21CrossRefGoogle Scholar 6. Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitz C, Schmitt A (2016) Decreased oligodendrocyte and neuron number in anterior hippocampal areas and the entire hippocampus in schizophrenia: a stereological postmortem study. Schizophr Bull 42(suppl1):S4–S12CrossRefGoogle Scholar 7. Falkai P, Steiner J, Malchow B, Shariati J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitt A (2016) Oligodendrocyte and interneuron density in hippocampal subfields in schizophrenia and association of oligodendrocyte number with cognitive deficits. Front Cell Neurosci 10:78CrossRefGoogle Scholar 8. Micheva KD, Wolman D, Mensh BD, Pax E, Buchanan J, Smith SJ, Bock DD (2016) A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons. Elife 6:5Google Scholar 9. Tomassy GS, Berger DR, Chen HH, Kasthuri N, Hayworth KJ, Vercelli A, Seung HS, Lichtman JW, Arlotta P (2014) Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex. Science 344(6181):319–324CrossRefGoogle Scholar 10. Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468(7321):244–252CrossRefGoogle Scholar Copyright information © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Authors and Affiliations Andrea Schmitt1Email authorMikael Simons234Ludovico Cantuti-Castelvetri2Peter Falkai11.Department of Psychiatry and Psychotherapy, University HospitalLMU MunichMunichGermany2.German Center for Neurodegenerative Diseases (DZNE)MunichGermany3.Munich Cluster for Systems Neurology (SyNergy)MunichGermany4.Institute of Neuronal Cell BiologyTechnical University MunichMunichGermany

This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs00406-019-01019-8.pdf

Andrea Schmitt, Mikael Simons, Ludovico Cantuti-Castelvetri, Peter Falkai. A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?, European Archives of Psychiatry and Clinical Neuroscience, 2019, 1-2, DOI: 10.1007/s00406-019-01019-8